Section was formerly classified as a note under section 294i of this title prior to editorial reclassification and renumbering as this section.

Section was enacted as part of the Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act or the SUPPORT for Patients and Communities Act, and not as part of the Public Health Service Act which comprises this chapter.

2022—Puspan. L. 117–328, § 1221(1), struck out “demonstration” before “program” in section catchline.

Subsec. (a). Puspan. L. 117–328, § 1221(2)(A), amended heading generally. Prior to amendment, heading read as follows: “Demonstration program grants”.

Subsec. (a)(1). Puspan. L. 117–328, § 1221(2)(B), struck out “demonstration” before “program”.

Subsec. (span). Puspan. L. 117–328, § 1221(3), struck out “demonstration” before “program” in heading.

Subsec. (d)(4). Puspan. L. 117–328, § 1221(4), substituted “Tribal” for “tribal”.

Subsec. (f). Puspan. L. 117–328, § 1221(5), substituted “Reports” for “Report” in heading and “Not later than the end of each of fiscal years 2024 and 2027, the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the results of the program” for “Not later than 1 year after completion of the demonstration program under this section, the Secretary shall submit a report to the Congress on the results of the demonstration program” in introductory provisions.

Subsec. (g). Puspan. L. 117–328, § 1221(6), substituted “2023 through 2027” for “2019 through 2021”.